What it isLong-acting dopamine partial agonist with serotonin-receptor activity; schizophrenia and maintenance of bipolar I disorder.
Why this oneUnlike aripiprazole lauroxil, it also carries a bipolar I maintenance indication.
What limits itInitiation needs two weeks of overlapping oral aripiprazole (or the two-injection start), and akathisia remains the characteristic complaint.
BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis treated with antipsychotics; not approved for dementia-related psychosis.
FDA dosing
Population
Start
Target
Max
Schizophrenia
Adults
See initiation (1-day or 14-day)
400 mg IM monthly
—
Bipolar I disorder (maintenance monotherapy)
Adults
See initiation (1-day or 14-day)
400 mg IM monthly
—
Renal Undefined
Hepatic Undefined
400 mg monthly, no sooner than 26 days after the previous injection
Instructions
IM (deltoid or gluteal) by a healthcare professional
Establish tolerability with oral aripiprazole first
1-day initiation: two 400 mg injections + oral aripiprazole 20 mg; or 14-day: 400 mg + 14 days oral aripiprazole 10–20 mg
May reduce to 300 mg monthly for adverse reactions
CYP2D6 poor metabolizers: 300 mg monthly
Cautions
Increased mortality in elderly with dementia-related psychosis (boxed) and cerebrovascular reactions/stroke